# FDA Inspection 1216334 - Sri Krishna Pharmaceuticals, Ltd. - Unit III - July 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-iii/bfd65ca0-6288-4752-be58-bf323fa42b5c
Source feed: FDA_Inspections

> FDA Inspection 1216334 for Sri Krishna Pharmaceuticals, Ltd. - Unit III on July 31, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216334
- Company Name: Sri Krishna Pharmaceuticals, Ltd. - Unit III
- Inspection Date: 2023-07-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 954833 - 2015-10-23](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-iii/2853273d-d209-4c2c-bc69-d55e0b02bd2c)
- [FDA Inspection 757343 - 2011-11-25](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-iii/6376ffda-dc3a-453c-b1d1-dd9887617578)

Company: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-iii/a5f2eafb-ac51-432f-af12-b1e114c64964

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c